Flagship Pioneering announced the launch of Apriori Bio, a health security company providing variant-proof protection against rapidly evolving viruses. Apriori has developed Octavia, a unique biology-informed AI platform that can infer the full landscape of potential variants for a given virus. Using Octavia, Apriori can define the antibody repertoire that most broadly protects against current and future virus variants, enabling the development of variant-proof vaccines and antibody drugs . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post Apriori Bio’s AI Platform Provides Variant-Proof Protection from Viral Threats appeared first on GEN – Genetic Engineering and Biotechnology News.
